html[data-identity='g1'] .g1-header .g1-header-wide .g1-header-layers button { display: none; } html[data-identity='g1'] .g1-header-wide .g1-header-layers a { align-self: center; } html[data-identity='g1'] .g1-header .g1-header-narrow { display: none; } html[data-identity='g1'] .g1-header-nojs { display: none; } @media (width < 721px) { html[data-identity='g1'] .g1-header .g1-header-nojs { display: flex; flex-wrap: wrap; column-gap: 20px; padding: 0 16px 8px; } html[data-identity='g1'] .g1-header-nojs ul { display: flex; gap: 20px; list-style: none; margin: 0; padding: 0; box-shadow: none; } html[data-identity='g1'] .g1-header-nojs a { display: block; padding: 6px 0; font-size: 15px; line-height: 24px; color: var(--ink2); text-decoration: none; } html[data-identity='g1'] .g1-header-nojs a[aria-current='true'] { color: var(--ink); text-decoration: underline 2px var(--ember); text-underline-offset: 6px; } }

PapersPMID:28526381

Medium-term effect of sublingual l-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors.

Nutrition (Burbank, Los Angeles County, Calif.)2017The record ↗

findings: 2
compound: 1
endpoints: 2

glutathione

lowersLDL cholesterol
lowersTotal cholesterol (TC)

Study, every finding: crossover · 16 participants
Dose studied, every finding: sublingual L-glutathione
Population, every finding: 16 healthy men with cardiovascular risk factors; abstract only, overall population

What moved

How to read these marks →

“In the overall population, a decrease in total and low-density lipoprotein cholesterol was highlighted after L-GSH supplementation compared with placebo (P = 0.023 and P = 0.04, respectively).”
- Decreases LDL cholesterol
  very limited
- Decreases total cholesterol (TC)
  very limited

Study record

Design: crossover trial
Species: human
Population: healthy men with cardiovascular risk factors
Participants: 16
Comparator: placebo
Duration: not reported
Endpoints measured: 6